PDLLA MICROSPHERES

Short Description:

PDLLA microspheres, sized 20~50μm, are a superior subcutaneous filler with faster degradation rates compared to PLLA. These biocompatible and biodegradable microspheres stimulate collagen regeneration and are now widely used in clinical aesthetic fillers.


  • CAS: 51056-13-9
  • Particle Size Specification: 20μm~40μm;20μm~50μm;30μm~50μm;40μm~60μm
  • Particle Size Customization: 10μm~100μm

Product Detail

PDLLA material prepared into microspheres is a subcutaneous stimulatory filler with excellent performance. It possesses similar characteristics to PLLA microspheres, but with a faster degradation rate both in vivo and in vitro. Overall, PDLLA microspheres, as a novel facial filler material, exhibit excellent biocompatibility, biodegradability, and the ability to stimulate collagen regeneration during degradation. At present, medical aesthetic filler products based on PDLLA microspheres have already been widely applied in clinical practice.
Product Index:

Item Unit Standard 
Reference Standard Method Result
Appearance / / / Optical Microscopy Spherical particle
Median Size(D50) μm 30 ± 5 / Laser Particle Analyzer 29.09
Intrinsic Viscosity [η] dL/g 0.64±0.05 / Refer to ASTM D 2857
in Cloroform 30℃
0.625
Weight-average

Molecular Weight

% ≤0.5 YY/T 0661-2017 GPC 0.45
Moisture % ≤ 0.5 YY/T 0661-2017 Karl Fischer Coulometric Titration 0.30
Monomer Residue ppm ICH Limit Value YY/T 0661-2017 GC Qualified
Methanol Solvent residue ppm ICH Limit Value YY/T 0661-2017 GC Qualified
Heavy Metal Residue (Pb) μg/g ≤10 YY/T 0661-2017 Colorimetric Method of
Chinese Pharmacopoeia
Qualified
Sn Residue μg/g ≤100 YY/T 0661-2017 ICP 61
Specific Optical Rotation ° -10 ~ 10 YY/T 0661-2017 Polarimetric Test of
Chinese Pharmacopoeia
in Dichloromethane, 20 ℃
-1.7

 *Produced in GMP workshop, each batch will provide the corresponding COA report.

Model No. Intrinsic Viscosity [η] (dL/g) Particle size range
MP-PDLLA02A 0.16-0.24 20-50
MP-PDLLA04A 0.32-0.48 20-50
MP-PDLLA10A 0.60-0.72 20-50

  • Previous:
  • Next:

  • Write your message here and send it to us